Skip to main content
Top
Published in: Virology Journal 1/2012

Open Access 01-12-2012 | Research

Molecular characterization of hepatitis c virus in multi-transfused Colombian patients

Authors: Diana di Filippo, Fabian Cortes-Mancera, Mauricio Beltran, Maria Patricia Arbelaez, Sergio Jaramillo, Juan Carlos Restrepo, Gonzalo Correa, Maria-Cristina Navas

Published in: Virology Journal | Issue 1/2012

Login to get access

Abstract

Background

Hepatitis C virus (HCV) infects 170 million persons worldwide and is a public health problem. Considering that HCV is principally transmitted by exposure to infected blood, multi-transfused patients constitute one of the most important risk groups in developing countries. To explore the dynamics of this infection in Colombia, we performed a study to determine the genotypes of HCV in a cohort of multi-transfused patients.

Results

The serum samples from patients positive for anti-HCV were evaluated for HCV RNA by nested-PCR of the 5’untranslated region (5’UTR). Viral genotype was determined by RFLP and/or automated sequencing. HCV subtype 1b was found in eight cases (66.7%) and subtype 1a in two cases (16.7%); seven isolates of subtype 1b were obtained from patients who had received the first transfusion before 1986. Either genotypes 2b (8.3%) or 3a (8.3%) were found in the remaining positive specimens.

Conclusions

This is the first HCV genotyping study developed in multi-transfused patients in Colombia where HCV subtype 1b was the most prevalent. The mutation G235A in the 5’UTR of three isolates generated an additional restriction site and an RFLP pattern different from those previously described for genotype 1.
Appendix
Available only for authorised users
Literature
1.
go back to reference Takada N, Takase S, Enomoto N, Takada A, Date T: Clinical backgrounds of the patients having different types of hepatitis C virus genomes. J Hepatol. 1992, 14: 35-40. 10.1016/0168-8278(92)90128-C.PubMedCrossRef Takada N, Takase S, Enomoto N, Takada A, Date T: Clinical backgrounds of the patients having different types of hepatitis C virus genomes. J Hepatol. 1992, 14: 35-40. 10.1016/0168-8278(92)90128-C.PubMedCrossRef
2.
go back to reference WHO: Global surveillance and control of hepatitis C. Report of a WHO consultation organized in collaboration with the viral hepatitis prevention board, antwerp, belgium. J Viral Hepat. 1999, 6: 35-47.CrossRef WHO: Global surveillance and control of hepatitis C. Report of a WHO consultation organized in collaboration with the viral hepatitis prevention board, antwerp, belgium. J Viral Hepat. 1999, 6: 35-47.CrossRef
3.
go back to reference Choo QL, Richman KH, Han JH, Berger K, Lee C, Dong C, Gallegos C, Coit D, Medina-Selby R, Barr PJ, Weiner AJ, Bradley DW, Kuo G, Houghton M: Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A. 1991, 88: 2451-2455. 10.1073/pnas.88.6.2451.PubMedPubMedCentralCrossRef Choo QL, Richman KH, Han JH, Berger K, Lee C, Dong C, Gallegos C, Coit D, Medina-Selby R, Barr PJ, Weiner AJ, Bradley DW, Kuo G, Houghton M: Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A. 1991, 88: 2451-2455. 10.1073/pnas.88.6.2451.PubMedPubMedCentralCrossRef
4.
go back to reference Penin F, Dubuisson J, Rey FA, Moradpour D, Pawlotsky JM: Structural biology of hepatitis C virus. Hepatology. 2004, 39: 5-19. 10.1002/hep.20032.PubMedCrossRef Penin F, Dubuisson J, Rey FA, Moradpour D, Pawlotsky JM: Structural biology of hepatitis C virus. Hepatology. 2004, 39: 5-19. 10.1002/hep.20032.PubMedCrossRef
5.
go back to reference Sanchez JL, Sjogren MH, Callahan JD, Watts DM, Lucas C, Abdel-Hamid M, Constantine NT, Hyams KC, Hinostroza S, Figueroa-Barrios R, Cuthie JC: Hepatitis C in Peru: risk factors for infection, potential iatrogenic transmission, and genotype distribution. AmJTrop Med Hyg. 2000, 63: 242-248. Sanchez JL, Sjogren MH, Callahan JD, Watts DM, Lucas C, Abdel-Hamid M, Constantine NT, Hyams KC, Hinostroza S, Figueroa-Barrios R, Cuthie JC: Hepatitis C in Peru: risk factors for infection, potential iatrogenic transmission, and genotype distribution. AmJTrop Med Hyg. 2000, 63: 242-248.
6.
go back to reference Simmonds P: Genetic diversity and evolution of hepatitis C virus–15 years on. J Gen Virol. 2004, 85: 3173-3188. 10.1099/vir.0.80401-0.PubMedCrossRef Simmonds P: Genetic diversity and evolution of hepatitis C virus–15 years on. J Gen Virol. 2004, 85: 3173-3188. 10.1099/vir.0.80401-0.PubMedCrossRef
7.
go back to reference Simmonds P, Mellor J, Sakuldamrongpanich T, Nuchaprayoon C, Tanprasert S, Holmes EC, Smith DB: Evolutionary analysis of variants of hepatitis C virus found in South-East Asia: comparison with classifications based upon sequence similarity. J Gen Virol. 1996, 77 (Pt 12): 3013-3024.PubMedCrossRef Simmonds P, Mellor J, Sakuldamrongpanich T, Nuchaprayoon C, Tanprasert S, Holmes EC, Smith DB: Evolutionary analysis of variants of hepatitis C virus found in South-East Asia: comparison with classifications based upon sequence similarity. J Gen Virol. 1996, 77 (Pt 12): 3013-3024.PubMedCrossRef
8.
go back to reference Delwart E, Slikas E, Stramer SL, Kamel H, Kessler D, Krysztof D, Tobler LH, Carrick DM, Steele W, Todd D, Wright DJ, Kleinman SH, Busch MP: Genetic diversity of recently acquired and prevalent HIV, hepatitis B virus, and hepatitis C virus infections in US blood donors. J Infect Dis. 2012, 205: 875-885. 10.1093/infdis/jir862.PubMedPubMedCentralCrossRef Delwart E, Slikas E, Stramer SL, Kamel H, Kessler D, Krysztof D, Tobler LH, Carrick DM, Steele W, Todd D, Wright DJ, Kleinman SH, Busch MP: Genetic diversity of recently acquired and prevalent HIV, hepatitis B virus, and hepatitis C virus infections in US blood donors. J Infect Dis. 2012, 205: 875-885. 10.1093/infdis/jir862.PubMedPubMedCentralCrossRef
10.
go back to reference Dubois F, Desenclos JC, Mariotte N, Goudeau A: Hepatitis C in a french population-based survey, 1994: seroprevalence, frequency of viremia, genotype distribution, and risk factors. The Collaborative Study Group. Hepatology. 1997, 25: 1490-1496. 10.1002/hep.510250630.PubMedCrossRef Dubois F, Desenclos JC, Mariotte N, Goudeau A: Hepatitis C in a french population-based survey, 1994: seroprevalence, frequency of viremia, genotype distribution, and risk factors. The Collaborative Study Group. Hepatology. 1997, 25: 1490-1496. 10.1002/hep.510250630.PubMedCrossRef
11.
go back to reference Pawlotsky JM, Tsakiris L, Roudot-Thoraval F, Pellet C, Stuyver L, Duval J, Dhumeaux D: Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis. 1995, 171: 1607-1610. 10.1093/infdis/171.6.1607.PubMedCrossRef Pawlotsky JM, Tsakiris L, Roudot-Thoraval F, Pellet C, Stuyver L, Duval J, Dhumeaux D: Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis. 1995, 171: 1607-1610. 10.1093/infdis/171.6.1607.PubMedCrossRef
12.
go back to reference Pybus OG, Cochrane A, Holmes EC, Simmonds P: The hepatitis C virus epidemic among injecting drug users. Infect Genet Evol. 2005, 5: 131-139. 10.1016/j.meegid.2004.08.001.PubMedCrossRef Pybus OG, Cochrane A, Holmes EC, Simmonds P: The hepatitis C virus epidemic among injecting drug users. Infect Genet Evol. 2005, 5: 131-139. 10.1016/j.meegid.2004.08.001.PubMedCrossRef
13.
go back to reference Silini E, Bono F, Cividini A, Cerino A, Maccabruni A, Tinelli C, Bruno S, Bellobuono A, Mondelli M: Molecular epidemiology of hepatitis C virus infection among intravenous drug users. J Hepatol. 1995, 22: 691-695. 10.1016/0168-8278(95)80225-8.PubMedCrossRef Silini E, Bono F, Cividini A, Cerino A, Maccabruni A, Tinelli C, Bruno S, Bellobuono A, Mondelli M: Molecular epidemiology of hepatitis C virus infection among intravenous drug users. J Hepatol. 1995, 22: 691-695. 10.1016/0168-8278(95)80225-8.PubMedCrossRef
14.
go back to reference van den Burg PJ, Vrielink H, Reesink HW: Donor selection: the exclusion of high risk donors?. Vox Sang. 1998, 74 (Suppl 2): 499-502.PubMedCrossRef van den Burg PJ, Vrielink H, Reesink HW: Donor selection: the exclusion of high risk donors?. Vox Sang. 1998, 74 (Suppl 2): 499-502.PubMedCrossRef
15.
go back to reference Williams AE, Thomson RA, Schreiber GB, Watanabe K, Bethel J, Lo A, Kleinman SH, Hollingsworth CG, Nemo GJ: Estimates of infectious disease risk factors in US blood donors. Retrovirus epidemiology donor study. JAMA. 1997, 277: 967-972. 10.1001/jama.1997.03540360035027.PubMedCrossRef Williams AE, Thomson RA, Schreiber GB, Watanabe K, Bethel J, Lo A, Kleinman SH, Hollingsworth CG, Nemo GJ: Estimates of infectious disease risk factors in US blood donors. Retrovirus epidemiology donor study. JAMA. 1997, 277: 967-972. 10.1001/jama.1997.03540360035027.PubMedCrossRef
17.
go back to reference Beltran M, Navas MC, De la Hoz F, Mercedes Munoz M, Jaramillo S, Estrada C, Del Pilar Cortes L, Arbelaez MP, Donado J, Barco G, Luna M, Uribe GA, de Maldonado A, Restrepo JC, Correa G, Borda P, Rey G, de Neira M, Estrada A, Yepes S, Beltran O, Pacheco J, Villegas I, Boshell J: Hepatitis C virus seroprevalence in multi-transfused patients in Colombia. J Clin Virol. 2005, 34 (Suppl 2): S33-S38.PubMedCrossRef Beltran M, Navas MC, De la Hoz F, Mercedes Munoz M, Jaramillo S, Estrada C, Del Pilar Cortes L, Arbelaez MP, Donado J, Barco G, Luna M, Uribe GA, de Maldonado A, Restrepo JC, Correa G, Borda P, Rey G, de Neira M, Estrada A, Yepes S, Beltran O, Pacheco J, Villegas I, Boshell J: Hepatitis C virus seroprevalence in multi-transfused patients in Colombia. J Clin Virol. 2005, 34 (Suppl 2): S33-S38.PubMedCrossRef
18.
go back to reference Mora MV, Romano CM, Gomes-Gouvea MS, Gutierrez MF, Carrilho FJ, Pinho JR: Molecular characterization, distribution, and dynamics of hepatitis C virus genotypes in blood donors in Colombia. J Med Virol. 2010, 82: 1889-1898. 10.1002/jmv.21908.PubMedCrossRef Mora MV, Romano CM, Gomes-Gouvea MS, Gutierrez MF, Carrilho FJ, Pinho JR: Molecular characterization, distribution, and dynamics of hepatitis C virus genotypes in blood donors in Colombia. J Med Virol. 2010, 82: 1889-1898. 10.1002/jmv.21908.PubMedCrossRef
19.
go back to reference Schmunis GA, Zicker F, Cruz JR, Cuchi P: Safety of blood supply for infectious diseases in latin american countries, 1994–1997. AmJTrop Med Hyg. 2001, 65: 924-930. Schmunis GA, Zicker F, Cruz JR, Cuchi P: Safety of blood supply for infectious diseases in latin american countries, 1994–1997. AmJTrop Med Hyg. 2001, 65: 924-930.
20.
go back to reference Gismondi MI, Becker PD, Valva P, Guzman CA, Preciado MV: Phylogenetic analysis of previously nontypeable hepatitis C virus isolates from Argentina. J Clin Microbiol. 2006, 44: 2229-2232. 10.1128/JCM.02569-05.PubMedPubMedCentralCrossRef Gismondi MI, Becker PD, Valva P, Guzman CA, Preciado MV: Phylogenetic analysis of previously nontypeable hepatitis C virus isolates from Argentina. J Clin Microbiol. 2006, 44: 2229-2232. 10.1128/JCM.02569-05.PubMedPubMedCentralCrossRef
21.
go back to reference Gismondi MI, Staendner LH, Grinstein S, Guzman CA, Preciado MV: Hepatitis C virus isolates from Argentina disclose a novel genotype 1-associated restriction pattern. J Clin Microbiol. 2004, 42: 1298-1301. 10.1128/JCM.42.3.1298-1301.2004.PubMedPubMedCentralCrossRef Gismondi MI, Staendner LH, Grinstein S, Guzman CA, Preciado MV: Hepatitis C virus isolates from Argentina disclose a novel genotype 1-associated restriction pattern. J Clin Microbiol. 2004, 42: 1298-1301. 10.1128/JCM.42.3.1298-1301.2004.PubMedPubMedCentralCrossRef
22.
go back to reference Babaylova E, Graifer D, Malygin A, Stahl J, Shatsky I, Karpova G: Positioning of subdomain IIId and apical loop of domain II of the hepatitis C IRES on the human 40S ribosome. Nucleic Acids Res. 2009, 37: 1141-1151.PubMedPubMedCentralCrossRef Babaylova E, Graifer D, Malygin A, Stahl J, Shatsky I, Karpova G: Positioning of subdomain IIId and apical loop of domain II of the hepatitis C IRES on the human 40S ribosome. Nucleic Acids Res. 2009, 37: 1141-1151.PubMedPubMedCentralCrossRef
23.
go back to reference Lytle JR, Wu L, Robertson HD: Domains on the hepatitis C virus internal ribosome entry site for 40s subunit binding. RNA. 2002, 8: 1045-1055. 10.1017/S1355838202029965.PubMedPubMedCentralCrossRef Lytle JR, Wu L, Robertson HD: Domains on the hepatitis C virus internal ribosome entry site for 40s subunit binding. RNA. 2002, 8: 1045-1055. 10.1017/S1355838202029965.PubMedPubMedCentralCrossRef
24.
go back to reference Siridechadilok B, Fraser CS, Hall RJ, Doudna JA, Nogales E: Structural roles for human translation factor eIF3 in initiation of protein synthesis. Science. 2005, 310: 1513-1515. 10.1126/science.1118977.PubMedCrossRef Siridechadilok B, Fraser CS, Hall RJ, Doudna JA, Nogales E: Structural roles for human translation factor eIF3 in initiation of protein synthesis. Science. 2005, 310: 1513-1515. 10.1126/science.1118977.PubMedCrossRef
25.
go back to reference Botero RC, Rojas E, Idrovo V, Ponce E, Sierra F: Genotipos del virus de la Hepatitis C (HCV) en Santa Fé de Bogotá. Rev Colomb Gastroenterol. 1997, 12: 15-20. Botero RC, Rojas E, Idrovo V, Ponce E, Sierra F: Genotipos del virus de la Hepatitis C (HCV) en Santa Fé de Bogotá. Rev Colomb Gastroenterol. 1997, 12: 15-20.
26.
go back to reference Correa G, Yepes A, Alvarez C, Restrepo JC, Zapata JC, Arango A: Genotipos virales en pacientes con infección por el virus de la hepatitis C en medellín. Gastroenerología y Hepatología. 2002, 25: 333-336. Correa G, Yepes A, Alvarez C, Restrepo JC, Zapata JC, Arango A: Genotipos virales en pacientes con infección por el virus de la hepatitis C en medellín. Gastroenerología y Hepatología. 2002, 25: 333-336.
27.
go back to reference Cortés A, Beltrán M, Olaya B, Hernández M: Riesgo de enfermedades infecciosas transmitidas por transfusión en el Valle del Cauca. Colomb Med. 1999, 30: 13-18. Cortés A, Beltrán M, Olaya B, Hernández M: Riesgo de enfermedades infecciosas transmitidas por transfusión en el Valle del Cauca. Colomb Med. 1999, 30: 13-18.
28.
go back to reference Santamaria C, Delima E, Holguín J: Hallazgos histológicos en infección crónica por el virus de la Hepatitis C y su correlación con el genotipo viral, en Cali. Colombia. Medical. 1998, 29: 20-23. Santamaria C, Delima E, Holguín J: Hallazgos histológicos en infección crónica por el virus de la Hepatitis C y su correlación con el genotipo viral, en Cali. Colombia. Medical. 1998, 29: 20-23.
29.
go back to reference Cortes-Mancera F, Loureiro CL, Hoyos S, Restrepo JC, Correa G, Jaramillo S, Norder H, Pujol FH, Navas MC: Etiology and viral genotype in patients with End-stage liver diseases admitted to a hepatology unit in colombia. Hepat Res Treat. 2011, 2011: 363205-PubMedPubMedCentral Cortes-Mancera F, Loureiro CL, Hoyos S, Restrepo JC, Correa G, Jaramillo S, Norder H, Pujol FH, Navas MC: Etiology and viral genotype in patients with End-stage liver diseases admitted to a hepatology unit in colombia. Hepat Res Treat. 2011, 2011: 363205-PubMedPubMedCentral
30.
go back to reference Djebbi A, Bahri O, Langar H, Sadraoui A, Mejri S, Triki H: Genetic variability of genotype 1 hepatitis C virus isolates from Tunisian haemophiliacs. New Microbiol. 2008, 31: 473-480.PubMed Djebbi A, Bahri O, Langar H, Sadraoui A, Mejri S, Triki H: Genetic variability of genotype 1 hepatitis C virus isolates from Tunisian haemophiliacs. New Microbiol. 2008, 31: 473-480.PubMed
31.
go back to reference Ferreira MR, Lonardoni MV, Bertolini DA: Hepatitis C: serological and molecular diagnosis and genotype in haemophilic patients at the Regional Hemocenter of Maringa, Maringa PR Brazil. Haemophilia. 2008, 1-6. Ferreira MR, Lonardoni MV, Bertolini DA: Hepatitis C: serological and molecular diagnosis and genotype in haemophilic patients at the Regional Hemocenter of Maringa, Maringa PR Brazil. Haemophilia. 2008, 1-6.
32.
go back to reference Beltrán MAM, Ching R: Situación actual del tamizaje en bancos de sangre. Biomedica. 1997, 16: 51-52. Beltrán MAM, Ching R: Situación actual del tamizaje en bancos de sangre. Biomedica. 1997, 16: 51-52.
33.
go back to reference Romano CM, de Carvalho-Mello IM, Jamal LF, de Melo FL, Iamarino A, Motoki M, Pinho JR, Holmes EC, de Andrade Zanotto PM: Social networks shape the transmission dynamics of hepatitis C virus. PLoS One. 2010, 5: e11170-10.1371/journal.pone.0011170.PubMedPubMedCentralCrossRef Romano CM, de Carvalho-Mello IM, Jamal LF, de Melo FL, Iamarino A, Motoki M, Pinho JR, Holmes EC, de Andrade Zanotto PM: Social networks shape the transmission dynamics of hepatitis C virus. PLoS One. 2010, 5: e11170-10.1371/journal.pone.0011170.PubMedPubMedCentralCrossRef
34.
go back to reference Freitas SZ, da Cunha RV, Martins RM, Teles SA, Ibanhes ML, Motta-Castro AR: Prevalence, genotypes and risk factors associated with hepatitis C virus infection in hemodialysis patients in Campo Grande, MS, Brazil. Mem Inst Oswaldo Cruz. 2008, 103: 405-408.PubMedCrossRef Freitas SZ, da Cunha RV, Martins RM, Teles SA, Ibanhes ML, Motta-Castro AR: Prevalence, genotypes and risk factors associated with hepatitis C virus infection in hemodialysis patients in Campo Grande, MS, Brazil. Mem Inst Oswaldo Cruz. 2008, 103: 405-408.PubMedCrossRef
35.
go back to reference Dencs A, Hettmann A, Martyin T, Jekkel C, Banyai T, Takacs M: Phylogenetic investigation of nosocomial transmission of hepatitis C virus in an oncology ward. J Med Virol. 2011, 83: 428-436. 10.1002/jmv.21983.PubMedCrossRef Dencs A, Hettmann A, Martyin T, Jekkel C, Banyai T, Takacs M: Phylogenetic investigation of nosocomial transmission of hepatitis C virus in an oncology ward. J Med Virol. 2011, 83: 428-436. 10.1002/jmv.21983.PubMedCrossRef
36.
go back to reference Chan SW, McOmish F, Holmes EC, Dow B, Peutherer JF, Follett E, Yap PL, Simmonds P: Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol. 1992, 73 (Pt 5): 1131-1141.PubMedCrossRef Chan SW, McOmish F, Holmes EC, Dow B, Peutherer JF, Follett E, Yap PL, Simmonds P: Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol. 1992, 73 (Pt 5): 1131-1141.PubMedCrossRef
37.
go back to reference Davidson F, Simmonds P, Ferguson JC, Jarvis LM, Dow BC, Follett EA, Seed CR, Krusius T, Lin C, Medgyesi GA, et al: Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region. J Gen Virol. 1995, 76 (Pt 5): 1197-1204.PubMedCrossRef Davidson F, Simmonds P, Ferguson JC, Jarvis LM, Dow BC, Follett EA, Seed CR, Krusius T, Lin C, Medgyesi GA, et al: Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region. J Gen Virol. 1995, 76 (Pt 5): 1197-1204.PubMedCrossRef
Metadata
Title
Molecular characterization of hepatitis c virus in multi-transfused Colombian patients
Authors
Diana di Filippo
Fabian Cortes-Mancera
Mauricio Beltran
Maria Patricia Arbelaez
Sergio Jaramillo
Juan Carlos Restrepo
Gonzalo Correa
Maria-Cristina Navas
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2012
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-9-242

Other articles of this Issue 1/2012

Virology Journal 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine